Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Interleukin
    (3)
  • P2X Receptor
    (2)
  • Apoptosis
    (1)
  • Epigenetic Reader Domain
    (1)
  • GPCR
    (1)
  • IDO
    (1)
  • IRAK
    (1)
  • Indoleamine 2,3-Dioxygenase (IDO)
    (1)
  • Phosphatase
    (1)
  • Others
    (5)
TargetMol | Tags By ResearchField
  • Inflammation
    (10)
  • Immune System
    (9)
  • Cancer
    (3)
  • Cardiovascular System
    (2)
Filter
Search Result
Results for "

autoimmunity inhibitor

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Azathioprine
    BW 57-322
    T1237446-86-6
    Azathioprine (BW 57-322), an immunosuppressive agent, inhibits purine synthesis and GTP-binding protein Rac1 activation.
    • $45
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • JAK2/STAT3-IN-1
    T727542485758-50-5In house
    JAK2/STAT3-IN-1 is a GP130 inhibitor with anti-tumor effects and can be used to study inflammation, autoimmunity and cancer.
    • $293 TargetMol
    In Stock
    Size
    QTY
  • Enpatoran
    T95702101938-42-3In house
    Enpatoran is an inhibitor of TLR7(IC50 = 11.1 nM) and TLR8(IC50 = 24.1 nM). Enpatoran was found to be inactive against TLR3, TLR4, and TLR9 in vitro and in vivo.
    • $122
    In Stock
    Size
    QTY
  • RVX-297
    RVX297
    T286281044871-04-6
    RVX-297 is a BD2 selective inhibitor of BET bromodomains. RVX-297 preferentially binds to the BD2 domains of the BET bromodomain and Extra Terminal (BET) family of protein.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • HG-12-6
    T115592222354-57-4
    HG-12-6 is a type II inhibitor of IRAK4, demonstrating preferential binding to unphosphorylated inactive IRAK4 (IC50: 165 nM) and modulating IRAK4 activity in autoimmunity and inflammation.
    • $2,720
    3-6 months
    Size
    QTY
  • LTV-1
    T11889347379-29-7
    LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM.
    • $688
    6-8 weeks
    Size
    QTY
  • Syk-IN-4
    T370772932264-95-2
    Syk-IN-4 is a potent, selective, and oral Syk inhibitor. It blocks immune receptor signaling, used for rheumatoid arthritis and autoimmune disease research.
    • $152
    In Stock
    Size
    QTY
  • IDO2-IN-1
    T638142803768-09-2
    IDO2-IN-1 is a potent, orally active indoleamine 2,3-dioxygenase 2 (IDO2) inhibitor, exhibiting an IC50 value of 112 nM. It is applicable in research related to inflammatory autoimmunity [1].
    • $1,520
    10-14 weeks
    Size
    QTY
  • P2X7-IN-2
    T733351058709-63-9
    P2X7-IN-2, a P2X7 receptor inhibitor, effectively suppresses IL-Iβ release, demonstrating an inhibitory concentration (IC50) value of 0.01 nM. This compound is utilized in the study of autoimmunity, inflammation, and cardiovascular disease.
    • $1,520
    6-8 weeks
    Size
    QTY
  • P2X7-IN-2 TFA
    T75254
    P2X7-IN-2 TFA (compound 58) is a P2X7 receptor inhibitor with an IC50 value of 0.01 nM for inhibiting IL-Iβ release, used in research on autoimmunity, inflammation, and cardiovascular disease [1].
    • Inquiry Price
    Inquiry
    Size
    QTY